Lixte Biotechnology Holdings, Inc. (LIXT) NASDAQ
3.11
-0.13(-4.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.11
-0.13(-4.01%)
Currency In USD
| Market Cap | 4.57M |
| Enterprise Value | 3.53M |
| P/E Ratio | -4.64 |
| PEG Ratio | -0.54 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.91 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.02 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.76 |
| Return On Equity | -2.19 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -3.57M |
| Net Income | -3.59M |
| Diluted EPS | -1.59 |
| Total Cash | 5.34M |
| Total Cash/Share | 0.87 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.42 |
| Book Value Per Share | 0.8 |
| 52-Week Change | 157.02 |
| 52-Week High | 6.26 |
| 52-Week Low | 0.64 |
| Moving Average 50 Days | 3.23 |
| Moving Average 200 Days | 3.64 |
| Average Volume | 74,533 |
| Shares Outstanding | 4.55M |
| % Held by Institutions | 1.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 05, 2023 |